Joan Montero

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Cell death & disease

Cancer research

Cell death discovery

NPJ precision oncology

Institute for Bioengineering of Catalonia

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Bioengineering of Catalonia

Spain

Ramon y Cajal Senior Researcher (Assistant Professor equivalent)

Dana-Farber Cancer Institute/Harvard Medical School/Brigham and Women's Hospital

United States

Instructor in Medicine

Dana Farber Cancer Institute

United States

Postdoctoral Fellow :: Medical Oncology

CIBERehd

Spain

REsearcher

Consejo Superior de Investigaciones Cientificas / Instituto de Investigaciones Biomedicas de Barcelona (CSIC-IIBB)

Spain

Predoctoral Fellow :: Muerte y proliferacion celular

Universitat de Barcelona

Spain

Undergraduate research collaborator :: Bioquimica

Education History

Universitat de Barcelona - Oct 03 2008

Spain

PHD :: Biologia cel.lular i anatomia patologica

Publications

Joan Montero, Rizwan Haq
Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics. Cancer discovery 12 (5) (2022)
Albert Manzano-Muñoz, José Yeste, María A Ortega, Fernando Martín Silva, Anna López, Jordi Rosell, Sandra Castro, César Serrano, Josep Samitier, Javier Ramon-Azcon, Joan Montero
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy. NPJ precision oncology 6 (1) (2022)
Clara Alcon, Fernando Martín Silva, Estela Prada, Jaume Mora, Aroa Soriano Fernandez, Gabriela Guillén Burrieza, Soledad Gallego Melcon, Josep Roma, Josep Samitier, Alberto Villanueva, Joan Montero
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment. Cell death discovery 8 (1) (2022)
Barbara Schroeder, Travis Vander Steen, Ingrid Espinoza, Chandra M Kurapaty Venkatapoorna, Zeng Hu, Fernando Martín Silva, Kevin Regan, Elisabet Cuyàs, X Wei Meng, Sara Verdura, Aina Arbusà, Paula A Schneider, Karen S Flatten, George Kemble, Joan Montero, Scott H Kaufmann, Javier A Menendez, Ruth Lupu
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells. Cell death & disease 12 (11) (2021)
Jorge Gomez Tejeda Zanudo, Pingping Mao, Clara Alcon, Kailey Kowalski, Gabriela N Johnson, Guotai Xu, Jose Baselga, Maurizio Scaltriti, Anthony G Letai, Joan Montero, Reka Albert, Nikhil Wagle
Cell Line-Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations. Cancer research 81 (17) (2021)
Clara Alcon, Albert Manzano-Muñoz, Estela Prada, Jaume Mora, Aroa Soriano Fernandez, Gabriela Guillén Burrieza, Soledad Gallego Melcon, Josep Roma, Josep Samitier, Alberto Villanueva, Joan Montero
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance. Cell death & disease 11 (8) (2020)
Clara Alcon, Albert Manzano-Muñoz, Joan Montero
A New CDK9 Inhibitor on the Block to Treat Hematologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)

Joan Montero.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joan Montero